{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cerebral+Vein+Thrombosis&page=2", "query": { "condition": "Cerebral Vein Thrombosis", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 25, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cerebral+Vein+Thrombosis&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cerebral+Vein+Thrombosis&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-09T05:36:05.206Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02585713", "title": "Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cerebral Vein Thrombosis", "Deep Vein Thrombosis", "Gonadal Thrombosis", "Hepatic Thrombosis", "Malignant Neoplasm", "Mesenteric Thrombosis", "Metastatic Malignant Neoplasm", "Portal Vein Thrombosis", "Pulmonary Embolism", "Renal Vein Thrombosis", "Splenic Thrombosis", "Venous Thromboembolism" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Dalteparin", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Academic and Community Cancer Research United", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2015-11-20", "completion_date": "2019-12-24", "has_results": true, "last_update_posted_date": "2020-08-04", "last_synced_at": "2026-10-09T05:36:05.206Z", "location_count": 18, "location_summary": "Scottsdale, Arizona • Jacksonville, Florida • Evanston, Illinois + 15 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Evanston", "state": "Illinois" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT02585713" }, { "nct_id": "NCT04535128", "title": "COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Covid19", "Thrombosis Embolism", "DVT", "Pulmonary Embolism", "Myocardial Infarction", "Stroke" ], "interventions": [ { "name": "No intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11000, "start_date": "2020-03-24", "completion_date": "2025-08-31", "has_results": false, "last_update_posted_date": "2025-09-16", "last_synced_at": "2026-10-09T05:36:05.206Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04535128" }, { "nct_id": "NCT02111564", "title": "A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Failure", "Respiratory Insufficiency", "Stroke Acute", "Infectious Diseases", "Rheumatic Diseases" ], "interventions": [ { "name": "Rivaroxaban, 10 mg", "type": "DRUG" }, { "name": "Rivaroxaban, 7.5 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 12024, "start_date": "2014-01-07", "completion_date": "2018-05-03", "has_results": true, "last_update_posted_date": "2019-11-25", "last_synced_at": "2026-10-09T05:36:05.206Z", "location_count": 135, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Sheffield, Alabama + 132 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Sheffield", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02111564" }, { "nct_id": "NCT02889562", "title": "Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Coronary Artery Bypass Grafting", "Postoperative Atrial Fibrilation", "Stroke", "Systemic Embolism", "Deep Venous Thrombosis" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanford Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 56, "start_date": "2016-09", "completion_date": "2019-05-11", "has_results": true, "last_update_posted_date": "2021-01-22", "last_synced_at": "2026-10-09T05:36:05.206Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02889562" }, { "nct_id": "NCT03081169", "title": "Timing of VTE Prophylaxis in TBI", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "TBI (Traumatic Brain Injury)", "VTE (Venous Thromboembolism)" ], "interventions": [ { "name": "Enoxaparin Sodium 150 MG/ML Prefilled Syringe", "type": "DRUG" }, { "name": "Heparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loyola University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2017-04-03", "completion_date": "2019-08-12", "has_results": false, "last_update_posted_date": "2019-08-16", "last_synced_at": "2026-10-09T05:36:05.206Z", "location_count": 1, "location_summary": "Maywood, Illinois", "locations": [ { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03081169" }, { "nct_id": "NCT07814118", "title": "Multimodal Physiologic State Intelligence Study", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Failure", "Cardiomyopathies", "Pulmonary Hypertension", "Myocarditis; Acute or Subacute", "Myocarditis Due to Drug", "Myocarditis Viral", "Pericardial Diseases", "Valvular Heart Diseases", "Hypertension", "Sepsis", "Acute Kidney Injury", "Pulmonary Edema - Acute", "Pulmonary Edema With Heart Failure", "Pulmonary Edemas", "Acute Respiratory Distress Syndrome", "Pulmonary Embolism Acute", "Pulmonary Embolism (Diagnosis)", "Pulmonary Embolism Acute Massive", "Pulmonary Embolism Subacute Massive", "Venous Thrombosis Pulmonary", "Venous Thrombosis (Disorder)", "Venous Thrombosis, Deep", "Peripheral Arterial Disease", "Peripheral Arterial Disease (PAD)", "Aortic Diseases", "Muskuloskeletal Diseases", "Brain Aging", "Brain Aneurysm", "Brain Aging Related Conditions", "Ultrasound", "Ultrasound Exams", "Ultrasound Guidance" ], "interventions": [ { "name": "OMNIPHYS Multimodal Ultrasound Imaging System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Truway Health, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25000, "start_date": "2026-09-02", "completion_date": "2046-09-15", "has_results": false, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-10-09T05:36:05.206Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07814118" }, { "nct_id": "NCT02032030", "title": "Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Attack", "Cardiac Arrest", "Congestive Heart Failure", "Atrial Fibrillation", "Angina", "Deep Vein Thrombosis", "Pulmonary Embolism", "Respiratory Arrest", "Respiratory Failure", "Pneumonia", "Gastrointestinal Bleed", "Stomach Ulcer", "Delirium", "Stroke", "Nerve Injury", "Surgical Wound Infection" ], "interventions": [], "intervention_types": [], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 73952, "start_date": "2012-07", "completion_date": "2020-10-21", "has_results": false, "last_update_posted_date": "2022-08-09", "last_synced_at": "2026-10-09T05:36:05.206Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02032030" }, { "nct_id": "NCT01014403", "title": "Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Venous Thromboembolism", "Traumatic Brain Injury" ], "interventions": [ { "name": "enoxaparin", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2009-11", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2021-01-13", "last_synced_at": "2026-10-09T05:36:05.206Z", "location_count": 2, "location_summary": "Dallas, Texas • Tyler, Texas", "locations": [ { "city": "Dallas", "state": "Texas" }, { "city": "Tyler", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01014403" }, { "nct_id": "NCT03281590", "title": "Stroke and Cerebrovascular Diseases Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stroke", "Acute Stroke", "Acute Brain Injury", "Ischemic Stroke", "Hemorrhagic Stroke", "Transient Ischemic Attack", "Subarachnoid Hemorrhage", "Cerebral Ischemia", "Cerebral Infarction", "Cerebral Stroke", "Venous Sinus Thrombosis, Cranial" ], "interventions": [], "intervention_types": [], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Year", "maximum_age": null, "sex": "ALL", "summary": "1 Year and older" }, "enrollment_count": 4594, "start_date": "2017-09-06", "completion_date": "2022-06-10", "has_results": false, "last_update_posted_date": "2022-08-22", "last_synced_at": "2026-10-09T05:36:05.206Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT03281590" }, { "nct_id": "NCT05628207", "title": "Evaluation of the SCALED (SCaling AcceptabLE cDs)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Traumatic Brain Injury", "Venous Thromboembolism" ], "interventions": [ { "name": "Observational", "type": "OTHER" }, { "name": "Observational-control", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15000, "start_date": "2023-05-16", "completion_date": "2027-03-01", "has_results": false, "last_update_posted_date": "2026-10-02", "last_synced_at": "2026-10-09T05:36:05.206Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05628207" } ] }